-
EP4189111
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4189111
| EP4189111 - METHODS FOR ISOLATING CELL-FREE DNA [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 08.08.2024 Database last updated on 24.08.2024 | |
| Former | Grant of patent is intended Status updated on 23.04.2024 | ||
| Former | Examination is in progress Status updated on 10.11.2023 | ||
| Former | Request for examination was made Status updated on 05.05.2023 | ||
| Former | The international publication has been made Status updated on 04.02.2022 | ||
| Former | unknown Status updated on 01.09.2021 | Most recent event Tooltip | 08.08.2024 | Deletion - Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | Applicant(s) | For all designated states Guardant Health, Inc. 3100 Hanover Street Palo Alto, CA 94304 / US | [2024/14] |
| Former [2023/23] | For all designated states Guardant Health, Inc. 505 Penobscot Drive Redwood City, CA 94063 / US | Inventor(s) | 01 /
JAIMOVICH, Ariel Redwood City, California 94063 / US | 02 /
DUENWALD, Sven Jeffrey Redwood City, California 94063 / US | 03 /
GRAUMAN, Peter Vilem Redwood City, California 94063 / US | 04 /
HE, Yupeng Redwood City, California 94063 / US | 05 /
EID, Charbel Said Redwood City, California 94063 / US | 06 /
AXELROD, Haley Dara Redwood City, California 94063 / US | [2023/23] | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2023/23] | Application number, filing date | 21758891.2 | 29.07.2021 | [2023/23] | WO2021US43780 | Priority number, date | US202063059029P | 30.07.2020 Original published format: US 202063059029 P | [2023/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022026761 | Date: | 03.02.2022 | Language: | EN | [2022/05] | Type: | A1 Application with search report | No.: | EP4189111 | Date: | 07.06.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.02.2022 takes the place of the publication of the European patent application. | [2023/23] | Search report(s) | International search report - published on: | EP | 03.02.2022 | Classification | IPC: | C12Q1/6806, C12Q1/6827 | [2023/23] | CPC: |
C12Q1/6806 (EP);
C12N15/1065 (US);
C12Q1/6827 (EP);
C12Q1/6886 (US);
C12Q2600/154 (US);
C12Q2600/156 (US)
| C-Set: |
C12Q1/6806, C12Q2523/125, C12Q2535/122, C12Q2537/159 (EP);
C12Q1/6827, C12Q2523/125, C12Q2535/122, C12Q2537/159 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/23] | Title | German: | VERFAHREN ZUR ISOLIERUNG VON ZELLFREIER DNA | [2023/23] | English: | METHODS FOR ISOLATING CELL-FREE DNA | [2023/23] | French: | COMPOSITIONS ET MÉTHODES POUR ISOLER DE L'ADN ACELLULAIRE | [2023/23] | Entry into regional phase | 24.02.2023 | National basic fee paid | 24.02.2023 | Designation fee(s) paid | 24.02.2023 | Examination fee paid | Examination procedure | deleted | Communication of intention to grant the patent | 24.02.2023 | Examination requested [2023/23] | 24.02.2023 | Date on which the examining division has become responsible | 15.09.2023 | Amendment by applicant (claims and/or description) | 09.11.2023 | Despatch of a communication from the examining division (Time limit: M04) | 08.03.2024 | Reply to a communication from the examining division | 24.04.2024 | Communication of intention to grant the patent | 08.08.2024 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | Fees paid | Renewal fee | 24.02.2023 | Renewal fee patent year 03 | 29.07.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2017190215 (UNIV HEALTH NETWORK [CA]); | [AD]WO2018119452 (GUARDANT HEALTH INC [US]); | [A]US2018305738 (KENNEDY ANDREW [US], et al) | by applicant | US5912148 | US6130073 | US6210891 | US6258568 | US2001053519 | US2003082600 | US6582908 | US2003152490 | US6818395 | US6833246 | US6911345 | US6969488 | US7115400 | US7169560 | US7170050 | US7282337 | US7302146 | US7313308 | US7329492 | US7476503 | US7482120 | US7501245 | US7537898 | US2011160078 | US2013244237 | US9598731 | US2017211143 | US9738894 | US9850523 | WO2018009723 | WO2018119452 | WO2019136413 | WO2015US42310 | WO2017US68329 | WO2020US16120 | WO2021US25201 |